Literature DB >> 21691914

ASNC model coverage policy: single photon myocardial perfusion imaging.

David G Wolinsky1, Dennis A Calnon, Christopher L Hansen, Wael Jaber, Howard C Lewin, Denise Merlino, Jeffrey A Rosenblatt, Senthil Sundaram, Mark I Travin, Andrew Van Tosh.   

Abstract

Mesh：

Year:  2011        PMID： 21691914     DOI： 10.1007/s12350-011-9395-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  3 in total

Review 1.  Cost-effectiveness of myocardial perfusion imaging: a summary of the currently available literature.

Authors:  Roger D Des Prez; Leslee J Shaw; Robert L Gillespie; Wael A Jaber; Gavin L Noble; Prem Soman; David G Wolinsky; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

2.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

3.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690
  3 in total
  1 in total

1.  Nuclear cardiology—taking the high road.

Authors: 
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.